Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.
about
Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in Smad3(-/-) mice with dysregulated TGFβSurface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene familyC4.4A as a candidate marker in the diagnosis of colorectal cancerMatrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cellsMolecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related geneGalectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocationPossible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significanceInfluences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinomaLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Why anti-Bcl-2 clinical trials fail: a solutionCell surface molecules and their prognostic values in assessing colorectal carcinomas.A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesisComprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells.5-Fluorouracil derivatives: a patent review.Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activityClinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.A glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsAn anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.Serum galectin-3 as a potential marker for gastric cancer.Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cellsGalectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis.Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide.Galectin-3 induces endothelial cell morphogenesis and angiogenesisTargeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal CancerSerum YKL-40 and colorectal cancer.The role of galectin-3 in cancer drug resistanceThe role of galectins in colorectal cancer progression.A matter of life, death and diseases: mitochondria from a proteomic perspective.Galectins as cancer biomarkers.KSHV downregulation of galectin-3 in Kaposi's sarcoma.Carbohydrate nanocarriers in biomedical applications: functionalization and construction.Development and Applications of Lectins as Biological Tools in Biomedical Research.Effect of galectin-3 on the behavior of Eca‑109 human esophageal cancer cells.Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.Effects of galectin-3 inhibition on endometrial cell cycle and adhesion.Biologic instability of pancreatic cancer xenografts in the nude mouse.Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells.
P2860
Q21559539-46950114-FFD0-4E74-BC63-5AA5E28AA320Q24309519-A83EC65D-8BF4-4D39-A9FE-BACB01A0080FQ24652981-D5E8DC16-E12A-4497-B18D-48FC8CA6BB56Q28118886-B7D5F94F-7EEF-4AFD-B0C7-07477724EBF4Q28138269-B99F5600-36D4-4DCB-8EFC-D5CFEF739716Q28198408-BC2A6BD2-7778-4050-9D60-5C50E7BF9FD4Q28214490-49373A68-197C-4604-83D0-59078D356C03Q28216866-D67AADB9-15FE-41D5-ADA5-0212A891ED41Q30366990-724F98DD-E980-4BC8-BFDE-4A863AEC566CQ33758493-460AD5F4-23A5-43BD-8DC1-437BB2724F80Q33818072-85111D1D-23A1-42E1-867E-4AEFBF7EBF21Q33867523-79F6DC40-4187-403B-A227-C61835934658Q33940919-632C1740-FF90-4DD7-83E5-D7F659207C5CQ34253978-ABC8BC4C-C5F8-4341-802C-6C72A9BAF7C0Q34343335-0F83A15D-439F-41F9-9001-8D68E5739DB0Q34474679-4F374626-5725-4197-9CBD-4CE82B9B4803Q34524965-8AFA35E5-01C8-4E44-9C3F-76469D9C2863Q35096060-02DC3F6F-0940-41D6-9115-50C9C7ED04EBQ35207994-011D6FC3-C998-4EC4-B5CF-190E7F433CE3Q35314084-A4006BAD-4247-4339-9B79-EA6BFCAE305DQ35746692-F51DCBD2-7570-47F2-ABAF-D350CBC85BBFQ35788712-45936373-AF8D-46E6-9C90-F189A42A20EAQ35809815-8B740871-E675-448F-B339-683924310E2AQ35809897-F62CC363-3F37-483B-9CFA-33DADA82A824Q36095578-FF36BC59-65DD-4D6F-83E5-545D1B76987DQ36619099-818509D0-69B4-4B01-8BFE-8A3C647EC781Q36838457-76DDBB48-56E7-47F1-823A-95E320D45E51Q37869015-6ABF1EE0-3A7E-42BA-8D39-191CFDCD99B3Q38081957-2E0E6FFF-B363-478B-85B3-981873A67859Q38105320-E079EBA9-4E22-48DB-948C-C9817521C5D7Q38418556-084D8FD6-020B-4C3D-A028-B2E22A4CE6B6Q38567851-B21B5A11-0CCB-4A21-AB9B-B7166F1AB347Q38569847-C099B0FF-9FB1-4030-ABD1-2C542EC3CC79Q38942488-3574F625-AE3C-4583-AF63-391BD5340541Q39359190-F81CAF91-2E1F-41EB-B737-12380EF3EC71Q39445066-7E60AB30-96AF-46CB-A210-ABB7FB6574A7Q39590802-7B8FCD65-4D02-4445-AB64-2787C187B183Q40074785-CB0B6806-7A9B-4622-9702-ACCE0D5C1399Q40876210-A79851DB-BECB-48D3-93D7-60F97B6847BAQ41020090-CC024566-5528-441C-84AF-6C7900B07CB3
P2860
Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Expression of an endogenous ga ...... stic progression in the colon.
@en
Expression of an endogenous ga ...... stic progression in the colon.
@nl
type
label
Expression of an endogenous ga ...... stic progression in the colon.
@en
Expression of an endogenous ga ...... stic progression in the colon.
@nl
prefLabel
Expression of an endogenous ga ...... stic progression in the colon.
@en
Expression of an endogenous ga ...... stic progression in the colon.
@nl
P2093
P1433
P1476
Expression of an endogenous ga ...... stic progression in the colon.
@en
P2093
P304
P356
10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#
P407
P577
1995-06-01T00:00:00Z